The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
CD4+ follicular helper T cell infiltration predicts breast cancer survival
Open accessAbstract
CD4⁺ T cells are critical regulators of immune responses, but their functional role in human breast cancer is relatively unknown. The goal of this study was to produce an image of CD4⁺ T cells infiltrating breast tumors using limited ex vivo manipulation to better understand the in vivo differences associated with patient prognosis. We performed comprehensive molecular profiling of infiltrating CD4⁺ T cells isolated from untreated invasive primary tumors and found that the infiltrating T cell subpopulations included follicular helper T (Tfh) cells, which have not previously been found in solid tumors, as well as Th1, Th2, and Th17 effector memory cells and Tregs. T cell signaling pathway alterations included a mixture of activation and suppression characterized by restricted cytokine/chemokine production, which inversely paralleled lymphoid infiltration levels and could be reproduced in activated donor CD4⁺ T cells treated with primary tumor supernatant. A comparison of extensively versus minimally infiltrated tumors showed that CXCL13-producing CD4⁺ Tfh cells distinguish extensive immune infiltrates, principally located in tertiary lymphoid structure germinal centers. An 8-gene Tfh signature, signifying organized antitumor immunity, robustly predicted survival or preoperative response to chemotherapy. Our identification of CD4⁺ Tfh cells in breast cancer suggests that they are an important immune element whose presence in the tumor is a prognostic factor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular portraits of human breast tumours
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,261
Sørlie, T., Perou, C. M., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., Hastie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191367098 · Cited by 10,938
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
Galon, J., Costes, A., Sanchez-Cabo, F., Kirilovsky, A., Mlecnik, B., Lagorce-Pagès, C., Tosolini, M., Camus, M., Berger, A., Wind, P., et al. (2006) · Science · doi:10.1126/science.1129139 · Cited by 6,516
Curiel, T. J., Coukos, G., Zou, L., Alvarez, X., Cheng, P., Mottram, P., Evdemon-Hogan, M., Conejo-Garcia, J. R., Zhang, L., Burow, M., et al. (2004) · Nature Medicine · doi:10.1038/nm1093 · Cited by 5,151
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
Shankaran, V., Ikeda, H., Bruce, A. T., White, J. M., Swanson, P. E., Old, L. J., & Schreiber, R. D. (2001) · Nature · doi:10.1038/35074122 · Cited by 2,896
Follicular Helper CD4 T Cells (T FH )
Crotty, S. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101400 · Cited by 2,738
Miyara, M., Yoshioka, Y., Kitoh, A., Shima, T., Wing, K., Niwa, A., Parizot, C., Taflin, C., Heike, T., Valeyre, D., et al. (2009) · Immunity · doi:10.1016/j.immuni.2009.03.019 · Cited by 2,291
Sotiriou, C., Wirapati, P., Loi, S., Harris, A., Fox, S., Smeds, J., Nordgren, H., Farmer, P., Praz, V., Haibe-Kains, B., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj052 · Cited by 2,063
Self-citationDenkert, C., Loibl, S., Noske, A., Roller, M., Müller, B. M., Komor, M., Budczies, J., Darb-Esfahani, S., Kronenwett, R., Hanusch, C., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.7370 · Cited by 1,762
NF-κB, the first quarter-century: remarkable progress and outstanding questions
Hayden, M. S., & Ghosh, S. (2012) · Genes & Development · doi:10.1101/gad.183434.111 · Cited by 1,693
Gene-Expression Signatures in Breast Cancer
Sotiriou, C., & Pusztai, L. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0801289 · Cited by 1,485
Self-citationBreitfeld, D., Ohl, L., Kremmer, E., Ellwart, J., Sallusto, F., Lipp, M., & Förster, R. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.11.1545 · Cited by 1,464
Tumor-Infiltrating CD8+Lymphocytes Predict Clinical Outcome in Breast Cancer
Mahmoud, S. M. A., Paish, E. C., Powe, D. G., Macmillan, R. D., Grainge, M. J., Lee, A. H. S., Ellis, I. O., & Green, A. R. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.5037 · Cited by 1,367
Mechanisms Underlying Lineage Commitment and Plasticity of Helper CD4 + T Cells
O’Shea, J. J., & Paul, W. E. (2010) · Science · doi:10.1126/science.1178334 · Cited by 1,336
Cxc Chemokine Receptor 5 Expression Defines Follicular Homing T Cells with B Cell Helper Function
Schaerli, P., Willimann, K., Lang, A. B., Lipp, M., Loetscher, P., & Moser, B. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.11.1553 · Cited by 1,261
Bates, G. J., Fox, S. B., Han, C., Leek, R. D., Garcia, J. F., Harris, A. L., & Banham, A. H. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.05.9584 · Cited by 1,200
Dieu-Nosjean, M.-C., Antoine, M., Danel, C., Heudes, D., Wislez, M., Poulot, V., Rabbe, N., Laurans, L., Tartour, E., de Chaisemartin, L., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.0284 · Cited by 1,031
The Humoral Immune System Has a Key Prognostic Impact in Node-Negative Breast Cancer
Schmidt, M., Böhm, D., von Törne, C., Steiner, E., Puhl, A., Pilch, H., Lehr, H.-A., Hengstler, J. G., Kölbl, H., & Gehrmann, M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5206 · Cited by 836
Biological Processes Associated with Breast Cancer Clinical Outcome Depend on the Molecular Subtypes
Desmedt, C., Haibe-Kains, B., Wirapati, P., Buyse, M., Larsimont, D., Bontempi, G., Delorenzi, M., Piccart, M., & Sotiriou, C. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4756 · Cited by 828
Self-citationKryczek, I., Banerjee, M., Cheng, P., Vatan, L., Szeliga, W., Wei, S., Huang, E., Finlayson, E., Simeone, D., Welling, T. H., et al. (2009) · Blood · doi:10.1182/blood-2009-03-208249 · Cited by 813
Partners in transcription: NFAT and AP-1
Macián, F., López-Rodríguez, C., & Rao, A. (2001) · Oncogene · doi:10.1038/sj.onc.1204386 · Cited by 766
Gobert, M., Treilleux, I., Bendriss-Vermare, N., Bachelot, T., Goddard-Leon, S., Arfi, V., Biota, C., Doffin, A. C., Durand, I., Olive, D., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2360 · Cited by 758
T-helper-1-cell cytokines drive cancer into senescence
Braumüller, H., Wieder, T., Brenner, E., Aßmann, S., Hahn, M., Alkhaled, M., Schilbach, K., Essmann, F., Kneilling, M., Griessinger, C., et al. (2013) · Nature · doi:10.1038/nature11824 · Cited by 720
Good-Jacobson, K. L., Szumilas, C. G., Chen, L., Sharpe, A. H., Tomayko, M. M., & Shlomchik, M. J. (2010) · Nature Immunology · doi:10.1038/ni.1877 · Cited by 691
Dual Roles of Immune Cells and Their Factors in Cancer Development and Progression
Zamarron, B. F., & Chen, W. (2011) · International Journal of Biological Sciences · doi:10.7150/ijbs.7.651 · Cited by 681
Follicular Helper T Cells: Lineage and Location
Fazilleau, N., Mark, L., McHeyzer-Williams, L. J., & McHeyzer-Williams, M. G. (2009) · Immunity · doi:10.1016/j.immuni.2009.03.003 · Cited by 590
Nielsen, J. S., Sahota, R. A., Milne, K., Kost, S. E., Nesslinger, N. J., Watson, P. H., & Nelson, B. H. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0234 · Cited by 553
Martinet, L., Garrido, I., Filleron, T., Le Guellec, S., Bellard, E., Fournie, J.-J., Rochaix, P., & Girard, J.-P. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0431 · Cited by 516
Teschendorff, A. E., Miremadi, A., Pinder, S. E., Ellis, I. O., & Caldas, C. (2007) · Genome Biology · doi:10.1186/gb-2007-8-8-r157 · Cited by 497
Leukocyte composition of human breast cancer
Ruffell, B., Au, A., Rugo, H. S., Esserman, L. J., Hwang, E. S., & Coussens, L. M. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1104303108 · Cited by 479
Rody, A., Holtrich, U., Pusztai, L., Liedtke, C., Gaetje, R., Ruckhaeberle, E., Solbach, C., Hanker, L., Ahr, A., Metzler, D., et al. (2009) · Breast Cancer Research · doi:10.1186/bcr2234 · Cited by 460
Molecular programming of B cell memory
McHeyzer-Williams, M., Okitsu, S., Wang, N., & McHeyzer-Williams, L. (2012) · Nature Reviews Immunology · doi:10.1038/nri3128 · Cited by 449
Bos, R., & Sherman, L. A. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1322 · Cited by 443
deLeeuw, R. J., Kost, S. E., Kakal, J. A., & Nelson, B. H. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3216 · Cited by 437
Coppola, D., Nebozhyn, M., Khalil, F., Dai, H., Yeatman, T., Loboda, A., & Mulé, J. J. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.03.007 · Cited by 434 · cited 2×
“Tertiary lymphoid structures (TLS) have been previously identified in lung and colorectal cancers, and their presence has been linked with positive patient prognosis (25–27).”
CD20+ B Cells: The Other Tumor-Infiltrating Lymphocytes
Nelson, B. H. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001323 · Cited by 416
The chemokine system and cancer
Balkwill, F. R. (2012) · The Journal of Pathology · doi:10.1002/path.3029 · Cited by 412
TCR ζ-chain downregulation: curtailing an excessive inflammatory immune response
Baniyash, M. (2004) · Nature Reviews Immunology · doi:10.1038/nri1434 · Cited by 344
de Chaisemartin, L., Goc, J., Damotte, D., Validire, P., Magdeleinat, P., Alifano, M., Cremer, I., Fridman, W.-H., Sautès-Fridman, C., & Dieu-Nosjean, M.-C. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0952 · Cited by 338
A clinically relevant gene signature in triple negative and basal-like breast cancer
Rody, A., Karn, T., Liedtke, C., Pusztai, L., Ruckhaeberle, E., Hanker, L., Gaetje, R., Solbach, C., Ahr, A., Metzler, D., et al. (2011) · Breast Cancer Research · doi:10.1186/bcr3035 · Cited by 338
Inflammation driven by tumour-specific Th1 cells protects against B-cell cancer
Haabeth, O. A. W., Lorvik, K. B., Hammarström, C., Donaldson, I. M., Haraldsen, G., Bogen, B., & Corthay, A. (2011) · Nature Communications · doi:10.1038/ncomms1239 · Cited by 318
A Three-Gene Model to Robustly Identify Breast Cancer Molecular Subtypes
Haibe-Kains, B., Desmedt, C., Loi, S., Culhane, A. C., Bontempi, G., Quackenbush, J., & Sotiriou, C. (2012) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djr545 · Cited by 313
Self-citationWest, N. R., Kost, S. E., Martin, S. D., Milne, K., deLeeuw, R. J., Nelson, B. H., & Watson, P. H. (2013) · British Journal of Cancer · doi:10.1038/bjc.2012.524 · Cited by 268
The prognostic significance of B lymphocytes in invasive carcinoma of the breast
Mahmoud, S. M. A., Lee, A. H. S., Paish, E. C., Macmillan, R. D., Ellis, I. O., & Green, A. R. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1620-1 · Cited by 261
Lymphocytes in cancer development: Polarization towards pro-tumor immunity
Ruffell, B., DeNardo, D. G., Affara, N. I., & Coussens, L. M. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2009.11.002 · Cited by 253
The impact of CCR7 and CXCR5 on lymphoid organ development and systemic immunity
Müller, G., Höpken, U. E., & Lipp, M. (2003) · Immunological Reviews · doi:10.1034/j.1600-065x.2003.00073.x · Cited by 251
Selection of CD8+PD-1+ Lymphocytes in Fresh Human Melanomas Enriches for Tumor-reactive T Cells
Inozume, T., Hanada, K.-I., Wang, Q. J., Ahmadzadeh, M., Wunderlich, J. R., Rosenberg, S. A., & Yang, J. C. (2010) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3181fad2b0 · Cited by 233
Bianchini, G., Qi, Y., Alvarez, R. H., Iwamoto, T., Coutant, C., Ibrahim, N. K., Valero, V., Cristofanilli, M., Green, M. C., Radvanyi, L., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.2419 · Cited by 228
Gene Modules and Response to Neoadjuvant Chemotherapy in Breast Cancer Subtypes: A Pooled Analysis
Ignatiadis, M., Singhal, S. K., Desmedt, C., Haibe-Kains, B., Criscitiello, C., Andre, F., Loi, S., Piccart, M., Michiels, S., & Sotiriou, C. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.5624 · Cited by 220
Self-citationLohr, M., Edlund, K., Botling, J., Hammad, S., Hellwig, B., Othman, A., Berglund, A., Lambe, M., Holmberg, L., Ekman, S., et al. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.01.036 · Cited by 214
Yau, C., Esserman, L., Moore, D. H., Waldman, F., Sninsky, J., & Benz, C. C. (2010) · Breast Cancer Research · doi:10.1186/bcr2753 · Cited by 212
How T Cells Earn the Follicular Rite of Passage
Vinuesa, C. G., & Cyster, J. G. (2011) · Immunity · doi:10.1016/j.immuni.2011.11.001 · Cited by 211
Alexe, G., Dalgin, G. S., Scanfeld, D., Tamayo, P., Mesirov, J. P., DeLisi, C., Harris, L., Barnard, N., Martel, M., Levine, A. J., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0539 · Cited by 207
The ubiquitin ligase Peli1 negatively regulates T cell activation and prevents autoimmunity
Chang, M., Jin, W., Chang, J.-H., Xiao, Y., Brittain, G. C., Yu, J., Zhou, X., Wang, Y.-H., Cheng, X., Li, P., et al. (2011) · Nature Immunology · doi:10.1038/ni.2090 · Cited by 201
Prognostic impact of B-cell density in cutaneous melanoma
Ladányi, A., Kiss, J., Mohos, A., Somlai, B., Liszkay, G., Gilde, K., Fejős, Z., Gaudi, I., Dobos, J., & Tímár, J. (2011) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-011-1071-x · Cited by 199
T‐cell subsets in the germinal center
Ramiscal, R. R., & Vinuesa, C. G. (2013) · Immunological Reviews · doi:10.1111/imr.12031 · Cited by 180
Th17 cells in cancer: help or hindrance?
Wilke, C. M., Kryczek, I., Wei, S., Zhao, E., Wu, K., Wang, G., & Zou, W. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr019 · Cited by 180
The Role and Regulation of Human Th17 Cells in Tumor Immunity
Ye, J., Livergood, R. S., & Peng, G. (2013) · The American Journal of Pathology · doi:10.1016/j.ajpath.2012.08.041 · Cited by 176
Coronella, J. A., Spier, C., Welch, M., Trevor, K. T., Stopeck, A. T., Villar, H., & Hersh, E. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.4.1829 · Cited by 171
Ghebeh, H., Tulbah, A. M., Mohammed, S. F., Elkum, N. B., Amer, S. M. B., Al‐Tweigeri, T., & Dermime, S. (2007) · International Journal of Cancer · doi:10.1002/ijc.22703 · Cited by 171
Ascierto, M. L., Kmieciak, M., Idowu, M. O., Manjili, R., Zhao, Y., Grimes, M., Dumur, C., Wang, E., Ramakrishnan, V., Wang, X.-Y., et al. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1470-x · Cited by 167
Naturally occurring B-cell responses to breast cancer
Coronella-Wood, J. A., & Hersh, E. M. (2003) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-003-0409-4 · Cited by 161
Ladoire, S., Arnould, L., Mignot, G., Coudert, B. P., Rébé, C., Chalmin, F., Vincent, J., Bruchard, M., Chauffert, B., Martin, F., et al. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0831-1 · Cited by 137
Activator protein 1 suppresses antitumor T-cell function via the induction of programmed death 1
Xiao, G., Deng, A., Liu, H., Ge, G., & Liu, X. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206370109 · Cited by 133
Panse, J., Friedrichs, K., Marx, A., Hildebrandt, Y., Luetkens, T., Bartels, K., Horn, C., Stahl, T., Cao, Y. W., Milde‐Langosch, K., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604621 · Cited by 132
Chtanova, T., Newton, R. A., Liu, S. M., Weininger, L., Young, T. R., Silva, D. G., Bertoni, F., Rinaldi, A., Chappaz, S., Sallusto, F., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.12.7837 · Cited by 131
Regulation of inducible BALT formation and contribution to immunity and pathology
Foo, S. Y., & Phipps, S. (2010) · Mucosal Immunology · doi:10.1038/mi.2010.52 · Cited by 129
Regulatory T cells and breast cancer: implications for immunopathogenesis
Watanabe, M. A. E., Oda, J. M. M., Amarante, M. K., & Voltarelli, J. C. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9247-y · Cited by 125
Th17 cells: positive or negative role in tumor?
Ji, Y., & Zhang, W. (2010) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-010-0849-6 · Cited by 116
Link, A., Hardie, D. L., Favre, S., Britschgi, M. R., Adams, D., Sixt, M., Cyster, J. G., Buckley, C. D., & Luther, S. A. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2010.12.039 · Cited by 114
Gene expression profiles during human CD4+ T cell differentiation
Lee, M. S., Hanspers, K., Barker, C. S., Korn, A. P., & McCune, J. M. (2004) · International Immunology · doi:10.1093/intimm/dxh112 · Cited by 107
Yoon, H. H., Orrock, J. M., Foster, N. R., Sargent, D. J., Smyrk, T. C., & Sinicrope, F. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042274 · Cited by 101
Kim, M., Grimmig, T., Grimm, M. R., Lazariotou, M., Meier, E. C., Rosenwald, A., Tsaur, I., Blaheta, R. A., Heemann, U. W., Germer, C., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053630 · Cited by 95
An immunologic portrait of cancer
Ascierto, M. L., Giorgi, V. D., Liu, Q., Bedognetti, D., Spivey, T., Murtas, D., Uccellini, L., Ayotte, B. D., Stroncek, D. F., Chouchane, L., et al. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-146 · Cited by 94
Zaunders, J., Munier, C. M. L., Kaufmann, D., Ip, S., Grey, P., Smith, D. E., Ramacciotti, T., Quan, D., Finlayson, R. J., Kaldor, J. M., et al. (2005) · Blood · doi:10.1182/blood-2005-01-0206 · Cited by 89
Tumor microenvironment and lymphocyte infiltration
Rahir, G., & Moser, M. (2012) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-012-1253-1 · Cited by 83
Functional differences between low- and high-affinity CD8+T cells in the tumor environment
Bos, R., Marquardt, K., Cheung, J., & Sherman, L. A. (2012) · OncoImmunology · doi:10.4161/onci.21285 · Cited by 80
Cutting Edge: Mouse Pellino-2 Modulates IL-1 and Lipopolysaccharide Signaling1
Yu, K., Kwon, H.-J., Norman, D. A., Vig, E., Goebl, M., & Harrington, M. (2002) · Journal of Immunology · doi:10.4049/jimmunol.169.8.4075 · Cited by 68
Kim, T. W., Yu, M., Zhou, H., Cui, W., Wang, J., DiCorleto, P. E., Fox, P. L., Xiao, H. Q., & Li, X. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.352625 · Cited by 67
Wang, C., Hillsamer, P., & Kim, C. H. (2011) · BMC Immunology · doi:10.1186/1471-2172-12-53 · Cited by 57
Razis, E. D., Kalogeras, K. T., Kotoula, V., Eleftheraki, A. G., Nikitas, N., Kronenwett, R., Timotheadou, E. T., Christodoulou, C., Pectasides, D. G., Gogas, H. J., et al. (2012) · Clinical Breast Cancer · doi:10.1016/j.clbc.2012.03.006 · Cited by 56
Crotty, S. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01117.x · Cited by 43
Viegas, M. S., do Carmo, A., Silva, T., et al. (2007) · Microbes and Infection · doi:10.1016/j.micinf.2007.03.003 · Cited by 38
Maletzki, C., Jahnke, A., Ostwald, C., Klar, E., Prall, F., & Linnebacher, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032639 · Cited by 38
Ravoet, M., Sibille, C., Gu‐Trantien, C., Libin, M., Haibe‐Kains, B., Sotiriou, C. P., Goldman, M., Roufosse, F. E., & Willard-Gallo, K. E. (2009) · Blood · doi:10.1182/blood-2008-08-175091 · Cited by 37
Self-citationGrange, C., Létourneau, J., Forget, M.-A., Godin-Ethier, J., Martin, J., Liberman, M., Latour, M., Widmer, H., Lattouf, J.-B., Piccirillo, C. A., et al. (2011) · Journal of Immunological Methods · doi:10.1016/j.jim.2011.07.002 · Cited by 29
The adaptive immune response to colorectal cancer: From the laboratory to clinical practice
Curtis, N. J., Primrose, J. M., Thomas, G. J., Mirnezami, A. H., & Ottensmeier, C. H. H. (2012) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2012.05.011 · Cited by 23
Mihalj, M., Kellermayer, Z., & Balogh, P. (2013) · International Immunology · doi:10.1093/intimm/dxt001 · Cited by 2
Cited by
The consensus molecular subtypes of colorectal cancer
Guinney, J., Dienstmann, R., Wang, X., de Reyniès, A., Schlicker, A., Soneson, C., Marisa, L., Roepman, P., Nyamundanda, G., Angelino, P., et al. (2015) · Nature Medicine · doi:10.1038/nm.3967 · Cited by 5,170
Salgado, R., Denkert, C., Demaria, S., Sirtaine, N., Klauschen, F., Pruneri, G., Wienert, S., Van den Eynden, G., Baehner, F. L., Penault-Llorca, F., et al. (2015) · Annals of Oncology · doi:10.1093/annonc/mdu450 · Cited by 3,113
Self-citationTriple-negative breast cancer: challenges and opportunities of a heterogeneous disease
Bianchini, G., Balko, J. M., Mayer, I. A., Sanders, M. E., & Gianni, L. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.66 · Cited by 3,079
B cells are associated with survival and immunotherapy response in sarcoma
Petitprez, F., de Reyniès, A., Keung, E. Z., Chen, T. W.-W., Sun, C.-M., Calderaro, J., Jeng, Y.-M., Hsiao, L.-P., Lacroix, L., Bougoüin, A., et al. (2020) · Nature · doi:10.1038/s41586-019-1906-8 · Cited by 1,942
Tertiary lymphoid structures in the era of cancer immunotherapy
Sautès-Fridman, C., Petitprez, F., Calderaro, J., & Fridman, W. H. (2019) · Nature reviews. Cancer · doi:10.1038/s41568-019-0144-6 · Cited by 1,884
Metadata
- Authors
- Gu-Trantien, C., Loi, S., Garaud, S., Equeter, C., Libin, M., de Wind, A., Ravoet, M., Le Buanec, H., Sibille, C., Manfouo-Foutsop, G., Veys, I., Haibe-Kains, B., Singhal, S. K., Michiels, S., Rothé, F., Salgado, R., Duvillier, H., Ignatiadis, M., Desmedt, C., Bron, D., Larsimont, D., Piccart, M., Sotiriou, C., & Willard-Gallo, K.
- Venue
- Journal of Clinical Investigation
- Published
- 2013-06-17
- Volume
- 123
- Issue
- 7
- Pages
- 2873-2892
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2149668671
- Cited by
- 1,070
- References
- 88
- FWCI
- 30.51
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.